Drug Type Small molecule drug |
Synonyms Compound D1 |
Target |
Mechanism AIFM2 inhibitors(apoptosis inducing factor mitochondria associated 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stroke | Preclinical | CN | 12 Jul 2024 |